Andere talen Aquestive Therapeutics, Inc.

Aandelen

AQST

US03843E1047

Geschatte realtime Cboe BZX Andere beurzen 20:00:28 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,335 ^USD	-0,74%		-15,64%	+62,88%

29/04	Aquestive Therapeutics krijgt goedkeuring van de FDA voor Libervant voor de behandeling van aanvallen bij kinderen	MT
29/04	Transcript : Aquestive Therapeutics, Inc. - Special Call

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children	29/04
Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film	29/04
Aquestive Therapeutics, Inc Receives U.S. FDA Approval and Market Access for Libervant? Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm? (epinephrine) Sublingual Film	29/04
Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET	25/04
Aquestive Therapeutics to Present Crossover Study Data for Libervant Buccal Film at 76th Annual Meeting of the American Academy of Neurology	15/04
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology	12/04
Aquestive Therapeutics, Inc. to Present Crossover Study Data for Libervant Buccal Film At 76th Annual Meeting of the American Academy of Neurology	12/04
Aquestive Therapeutics Files $250 Million Mixed Shelf	03/04
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive	01/04
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive	01/04
Aquestive Therapeutics, Inc. Appoints Abigail Jenkins to Board of Directors, Effective April 1, 2024	01/04
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock	25/03
Top Midday Decliners	20/03
Sector Update: Health Care Stocks Steady Premarket Wednesday	20/03
Wall Street Set to Open Flat as Investors Look Toward Fed Decision; Oil Prices Drop Sharply	20/03
Top Premarket Decliners	20/03
Aquestive Therapeutics Prices $75 Million Common Stock Offering; Shares Slump Premarket	20/03
Aquestive Therapeutics Prices $75 Million Common Stock Offering	20/03
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock	20/03
Aquestive Therapeutics Proposes Public Stock Offering -- Shares Drop	19/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Aquestive Therapeutics, Inc.

Aandelen

AQST

US03843E1047

Andere talen

Filters